Nxera Pharma (SOLTF) Stock Chart & Stock Price History $6.50 +0.28 (+4.50%) As of 08/11/2025 09:35 AM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesShort InterestBuy This Stock Nxera Pharma Stock Price Performance The Nxera Pharma (SOLTF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 35.96%, with a year-to-date return of 5.56%. In the past month, the stock has increased 4.84%, reflecting recent market activity. As of the latest close, Nxera Pharma traded at $6.50 with a market cap of and volume of 100 shares. Five years ago, the stock traded at $13.70, representing a 52.55% decrease over that period. At the time, it had a market cap of and a volume of 0 shares. Receive SOLTF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nxera Pharma and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.50%1 Month Performance+4.84%3 Month PerformanceN/AYear-To-Date PerformanceN/A1 Year PerformanceN/A5 Year PerformanceN/A SOLTF Stock Chart for Tuesday, August, 12, 2025 SOLTF Chart by TradingView Nxera Pharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/11/2025$6.22$6.50+4.50%$6.50$6.50100 shs$0.0008/07/2025$6.22$6.22$6.22$6.22500 shs$0.0008/06/2025$6.22$6.22$6.22$6.22500 shs$0.0008/05/2025$6.20$6.22+0.32%$6.22$6.22500 shs$0.0007/31/2025$6.20$6.20$6.20$6.201,300 shs$0.0007/30/2025$6.39$6.20-2.97%$6.20$6.201,300 shs$0.0007/29/2025$6.39$6.39$6.39$6.3925 shs$0.0007/28/2025$6.15$6.39+3.90%$6.39$6.3925 shs$0.0007/25/2025$6.10$6.15+0.82%$6.15$6.152,100 shs$0.0007/24/2025$5.69$6.10+7.21%$6.10$6.101,300 shs$0.00 Get the Latest News and Ratings for SOLTF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nxera Pharma and its competitors with MarketBeat's FREE daily newsletter. 07/17/2025$5.69$5.69$5.69$5.69200 shs$0.0007/16/2025$5.86$5.69-2.86%$5.69$5.69200 shs$0.0007/15/2025$5.86$5.86$6.06$5.86600 shs$0.0007/14/2025$6.20$5.86-5.53%$6.06$5.86600 shs$0.0007/11/2025$6.20$6.20$6.20$6.201,600 shs$0.00 Related Companies 180 Life Sciences Stock Price Chart 3SBio Stock Price Chart 60 Degrees Pharmaceuticals Stock Price Chart Abcam Stock Price Chart Agentix Stock Price Chart AIM ImmunoTech Stock Price Chart Algernon Pharmaceuticals Stock Price Chart ALK-Abelló A/S Stock Price Chart Alpha Tau Medical Stock Price Chart Apollomics Stock Price Chart Receive SOLTF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nxera Pharma and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:SOLTF) was last updated on 8/12/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | SponsoredTurn your "dead money" into $306+ monthly (starting this month)Turn your "dead money" into $306+ monthly (starting this month) I've been tracking a financial revolution t...Investors Alley | SponsoredMy shocking meeting in Washington, D.C.After a shocking discovery in D.C., Jeff Brown is revealing: President Trump’s “Project MAFA” Get a look...Brownstone Research | SponsoredBig Changes Coming in August — Is Your IRA Ready?Banks aren’t waiting for the headlines to catch up. They’ve already started moving their wealth out of pape...Reagan Gold Group | SponsoredTop Picks for Trump’s Pro-Crypto America27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredSilver Demand Is Exploding—and Supply Can’t Keep UpElon's Next Market Move Could Send Silver Soaring Every industry Elon Musk touches explodes—from Tesla to S...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nxera Pharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nxera Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access